• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.

作者信息

Lazaridou Ingrid, Ram-Wolff Caroline, Bouaziz Jean-David, Bégon Edouard, Battistella Maxime, Rivet Jacqueline, Jachiet Marie, Bagot Martine, de Masson Adèle

机构信息

Department of Dermatology, Research Unit INSERM U976, Saint-Louis Hospital, FR-75010 Paris, France.

出版信息

Acta Derm Venereol. 2020 Sep 30;100(16):adv00271. doi: 10.2340/00015555-3576.

DOI:10.2340/00015555-3576
PMID:32556342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9234988/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b583/9234988/68a23dc855f5/ActaDV-100-16-5826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b583/9234988/68a23dc855f5/ActaDV-100-16-5826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b583/9234988/68a23dc855f5/ActaDV-100-16-5826-g001.jpg

相似文献

1
Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.度普利尤单抗治疗两名皮肤T细胞淋巴瘤患者
Acta Derm Venereol. 2020 Sep 30;100(16):adv00271. doi: 10.2340/00015555-3576.
2
Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.揭开伪装者的面纱：度普利尤单抗治疗后揭示蕈样肉芽肿
J Am Acad Dermatol. 2023 Jun;88(6):e305-e306. doi: 10.1016/j.jaad.2023.01.047. Epub 2023 Feb 28.
3
Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.使用度普利尤单抗后蕈样肉芽肿或塞扎里综合征的诊断：一项系统评价
J Am Acad Dermatol. 2023 May;88(5):1164-1166. doi: 10.1016/j.jaad.2022.12.001. Epub 2022 Dec 5.
4
Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.侵袭性皮肤 T 细胞淋巴瘤患者的生存和预后因素。
Acta Derm Venereol. 2022 Mar 22;102:adv00676. doi: 10.2340/actadv.v102.1087.
5
[Quality of life of patients with mycosis fungoides and Sézary syndrome].[蕈样肉芽肿和塞扎里综合征患者的生活质量]
Dermatologie (Heidelb). 2022 Oct;73(10):759-764. doi: 10.1007/s00105-022-05049-7. Epub 2022 Sep 8.
6
Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.聚焦莫格利珠单抗 - Kpkc 在成人复发或难治性蕈样真菌病或塞扎里综合征中的应用：疗效、安全性和患者选择。
Drug Des Devel Ther. 2020 Sep 16;14:3747-3754. doi: 10.2147/DDDT.S185896. eCollection 2020.
7
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.原发性皮肤 T 细胞淋巴瘤（蕈样肉芽肿和赛泽里综合征）：第一部分。诊断：临床和组织病理学特征以及新的分子和生物学标志物。
J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.
8
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.在 UK 蕈样肉芽肿或塞扎里综合征皮肤 T 细胞淋巴瘤中，总体生存率：莫格利珠单抗与当前标准治疗的比较效果。
J Comp Eff Res. 2023 Oct;12(10):e230017. doi: 10.57264/cer-2023-0017. Epub 2023 Aug 29.
9
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.皮肤T细胞淋巴瘤患者对局部氮芥疗法皮肤不耐受的前瞻性研究。法国皮肤淋巴瘤研究小组。
Arch Dermatol. 1999 Nov;135(11):1349-53. doi: 10.1001/archderm.135.11.1349.
10
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.原发性皮肤 T 细胞淋巴瘤除蕈样真菌病和赛泽里综合征以外。第一部分：临床和组织学特征及诊断。
J Am Acad Dermatol. 2021 Nov;85(5):1073-1090. doi: 10.1016/j.jaad.2021.04.080. Epub 2021 Apr 30.

引用本文的文献

1
Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review.度普利尤单抗治疗难治性皮肤扁平苔藓年轻女性的疗效：基于病例的综述
Diseases. 2025 Jul 18;13(7):225. doi: 10.3390/diseases13070225.
2
Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and Recommendations.度普利尤单抗治疗特应性皮炎患者后发生的皮肤T细胞淋巴瘤：临床综述与建议
Am J Clin Dermatol. 2025 May 26. doi: 10.1007/s40257-025-00955-7.
3
Case Report: Cutaneous T-cell lymphoma associated with biologic therapy: three cases and a literature review.

本文引用的文献

1
Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients.度普利尤单抗治疗后皮肤T细胞淋巴瘤进展：7例患者病例回顾
J Am Acad Dermatol. 2020 Jul;83(1):197-199. doi: 10.1016/j.jaad.2020.03.050. Epub 2020 Mar 27.
2
Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments.蕈样肉芽肿和 Sézary 综合征患者的临床严重程度指标及生活质量负担：通用工具与皮肤科专用工具的比较
J Eur Acad Dermatol Venereol. 2020 May;34(5):995-1003. doi: 10.1111/jdv.16021. Epub 2020 Jan 30.
3
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
病例报告：与生物治疗相关的皮肤T细胞淋巴瘤：三例报告及文献综述
Front Med (Lausanne). 2025 Apr 28;12:1544912. doi: 10.3389/fmed.2025.1544912. eCollection 2025.
4
Mycosis fungoides unveiled following dupilumab treatment in a patient with a history of atopic dermatitis. Usefulness of HFUS in monitoring skin features. A review with a case report.在一名有特应性皮炎病史的患者中，度普利尤单抗治疗后出现蕈样肉芽肿。高频超声在监测皮肤特征方面的实用性。附病例报告的综述。
Postepy Dermatol Alergol. 2025 Feb;42(1):5-12. doi: 10.5114/ada.2024.143463. Epub 2024 Sep 25.
5
Tumors in the setting of dupilumab use: A review of the literature.度普利尤单抗使用情况下的肿瘤：文献综述
World Allergy Organ J. 2024 Dec 11;18(1):101006. doi: 10.1016/j.waojou.2024.101006. eCollection 2025 Jan.
6
Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.使用度普利尤单抗治疗特应性皮炎后皮肤T细胞淋巴瘤发生风险增加。
Dermatol Ther. 2024 Jan;2024. doi: 10.1155/2024/9924306. Epub 2024 Aug 14.
7
Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma.白细胞介素-4和白细胞介素-13在皮肤T细胞淋巴瘤中的作用
Life (Basel). 2024 Feb 9;14(2):245. doi: 10.3390/life14020245.
8
Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.解析皮肤 T 细胞淋巴瘤中的肿瘤细胞进化：蕈样肉芽肿和 Sezary 综合征中的不同分化轨迹。
J Invest Dermatol. 2024 May;144(5):1088-1098. doi: 10.1016/j.jid.2023.10.018. Epub 2023 Nov 28.
9
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.原发性皮肤 T 细胞淋巴瘤瘙痒机制及其潜在治疗方法的最新进展。
Clin Exp Med. 2023 Dec;23(8):4177-4197. doi: 10.1007/s10238-023-01141-x. Epub 2023 Aug 9.
10
Dupilumab-associated mycosis fungoides: a cross-sectional study.达必妥相关蕈样肉芽肿：一项横断面研究。
Arch Dermatol Res. 2023 Nov;315(9):2561-2569. doi: 10.1007/s00403-023-02652-z. Epub 2023 Jun 4.
度普利尤单抗治疗伴有鼻息肉的重度慢性鼻-鼻窦炎患者的疗效和安全性（LIBERTY NP SINUS-24 和 LIBERTY NP SINUS-52）：两项多中心、随机、双盲、安慰剂对照、平行分组 3 期临床试验的结果。
Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19.
4
Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis.度普利尤单抗治疗误诊为特应性皮炎后蕈样肉芽肿的诊断
Acta Derm Venereol. 2019 Jul 1;99(9):818-819. doi: 10.2340/00015555-3208.
5
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.两项度普利尤单抗治疗特应性皮炎的 3 期临床试验。
N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30.
6
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.恶性细胞产生的 TH2 细胞因子抑制 TH1 反应，并在白血病皮肤 T 细胞淋巴瘤中强制形成全身性 TH2 偏向。
Clin Cancer Res. 2013 Jul 15;19(14):3755-63. doi: 10.1158/1078-0432.CCR-12-3488. Epub 2013 Jun 19.